TORNTPHARM.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 11:59):

Stats
Dagens volum	217 666
Gjennomsnittsvolum	255 723
Markedsverdi	909.55B
EPS	INR0 ( 2024-02-02 )
Neste inntjeningsdato	( INR0 ) 2024-05-28
Last Dividend	INR8.00 ( 2023-06-23 )
Next Dividend	INR0 ( N/A )
P/E	60.90
ATR14	INR4.03 (0.15%)

Volum Korrelasjon

Lang: 0.35 (neutral)

Kort: -0.57 (weak negative)

Signal:(68.697) Neutral

Torrent Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Torrent Pharmaceuticals Korrelasjon - Valuta/Råvare

0.15
( neutral )

0.24
( neutral )

-0.31
( neutral )

0.31
( neutral )

0.56
( weak )

-0.82
( strong negative )

Torrent Pharmaceuticals Økonomi

Annual	2022
Omsetning:	INR94.64B
Bruttogevinst:	INR67.29B (71.10 %)
EPS:	INR36.79

FY	2022
Omsetning:	INR94.64B
Bruttogevinst:	INR67.29B (71.10 %)
EPS:	INR36.79

FY	2022
Omsetning:	INR84.19B
Bruttogevinst:	INR58.81B (69.86 %)
EPS:	INR22.97

FY	2021
Omsetning:	INR78.86B
Bruttogevinst:	INR56.51B (71.66 %)
EPS:	INR36.99

Financial Reports:

No articles found.

Torrent Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR14.00 (N/A)	INR8.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Torrent Pharmaceuticals Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.99 - low (32.75%) | Divividend Growth Potential Score: 4.26 - Stable (14.82%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.500	2003-06-10
Last Dividend	INR8.00	2023-06-23
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	32	--
Total Paid Out	INR130.50	--
Avg. Dividend % Per Year	0.85%	--
Score	2.4	--
Div. Sustainability Score	3.99
Div.Growth Potential Score	4.26
Div. Directional Score	4.13	--

Next Divdend (Est)
(2024-09-12)

INR8.12 Estimate 6.85 %

Dividend Stability

0.27 Very Poor

Dividend Score

2.40

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR7.00	1.01%
2019	INR8.50	0.96%
2020	INR7.50	0.81%
2021	INR17.50	1.25%
2022	INR20.00	1.23%
2023	INR22.00	1.42%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
PRAJIND.NS	Dividend Junior	2023-07-19	Annually	22	0.83%
KABRAEXTRU.NS	Dividend Junior	2023-07-13	Annually	23	0.83%
DVL.NS	Dividend Junior	2023-09-13	Annually	17	1.37%
ADANIENT.NS	Dividend Junior	2023-07-06	Annually	23	0.08%
STARPAPER.NS	Dividend Junior	2023-09-15	Sporadic	22	1.19%
MUNJALAU.NS	Dividend Junior	2023-08-24	Sporadic	19	1.47%
HINDCOMPOS.NS	Dividend Junior	2023-09-22	Annually	23	0.50%
BODALCHEM.NS	Dividend Junior	2023-09-22	Annually	14	0.38%
RELAXO.NS	Dividend Junior	2023-08-17	Annually	14	0.17%
KRBL.NS	Dividend Junior	2023-08-25	Annually	23	0.61%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.146	1.500	7.09	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.233	1.500	8.52	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6.33	1.000	8.77	8.77	[3 - 30]
operatingCashFlowPerShareTTM	47.33	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	47.33	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.737	1.000	1.045	1.045	[0.2 - 0.8]
operatingProfitMarginTTM	0.234	1.000	7.32	7.32	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.99

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	60.69	1.000	3.97	0	[1 - 100]
returnOnEquityTTM	0.233	2.50	9.05	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	47.33	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	1.113	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	47.33	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-1.600	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.155	1.000	8.62	0	[0.1 - 0.5]
Total Score				4.26

Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.